Standout Papers

Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage 2022 2026 2023 2024116
  1. Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage (2022)
    Alessio D. Nahmad, Eli Reuveni et al. Nature Biotechnology

Immediate Impact

10 by Nobel laureates 41 from Science/Nature 92 standout
Sub-graph 1 of 19

Citing Papers

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
2024 StandoutNature

Works of Rami Khosravi being referenced

Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
2022 Standout

Author Peers

Author Last Decade Papers Cites
Rami Khosravi 1151 503 331 14 1.4k
Sharon Biton 1260 382 359 13 1.5k
R T Bronson 1202 561 299 13 1.6k
Andrei Zlobin 1096 373 254 18 1.4k
Hena R. Ashar 1168 517 380 13 1.6k
Lauren D. Wood 1244 578 334 20 1.7k
Wouter Nijkamp 1310 398 259 9 1.6k
Brett Milash 793 550 414 30 1.5k
P Jeanteur 1069 386 193 22 1.5k
Alexandra Bell 701 678 217 12 1.3k
Claire Attwooll 948 371 256 12 1.3k

All Works

Loading papers...

Rankless by CCL
2026